Skip to content

Contact +44 (0) 20 7060 7474 email us

Wound care

Wound Treatments in Switzerland

 

Publication Date April 2009
Publisher Euromonitor International
Product Type Report
Pages 32
ISBN Number not applicable
Product Code EUR00997

Price

£560.00
approximately: $848 | €625

pdf immediate delivery

Buy Now

print

Buy Now

Order above formats by FAX

Order by Fax

Summary

Euromonitor International's Wound Treatments in Switzerland report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data (2003-2008), allowing you to identify the sectors driving growth. It identifies the leading companies, the leading brands and offers strategic analysis of key factors influencing the market- be they new product developments, distribution or pricing issues. Forecasts to 2013 illustrate how the market is set to change.

Product coverage: sticking plasters, other wound treatments

Data coverage: market sizes (historic and forecasts), company shares and brand shares

Why buy this report?

  • Get a detailed picture of the wound treatments industry
  • Identify growth sectors and factors driving change
  • Understand the competitive environment, the market's major players and leading brands
  • Use five-year forecasts to assess how the market is predicted to develop

Euromonitor International has over 30 years experience of publishing market research reports, business reference books and online information systems. With offices in London, Chicago, Singapore, Shanghai, Vilnius, Dubai, Cape Town and Santiago and a network of over 600 analysts worldwide, Euromonitor has a unique capability to develop reliable information resources to help drive informed strategic planning

Contents

  • Wound Treatments in Switzerland
  • Euromonitor International
  • April 2009
  • Executive Summary
  • Healthy Market Performance Experienced in 2008
  • Key Market Drivers in the Swiss OTC Healthcare Market
  • Roche Pharma Leads Switzerland OTC Healthcare Market
  • Share of Grocery Retailers Increases
  • Positive But Slow Constant Value Growth Expected
  • Key Trends and Developments
  • Emphasis on Healthy Diets and Lifestyle Behaviour
  • Rising Healthcare Cost Drives More Self-medication
  • Population Is Ageing and Women Are Having Fewer Children
  • Changes in Weather Patterns Affect Allergy Sufferers
  • Market Indicators
  • Market Data
  • $1OTC Registration and Classification
  • Vitamins & Dietary Supplements Registration and Classification
  • EU Legislation
  • Self-medication and Preventive Medicine
  • Generics
  • Switches
  • Definitions
  • Bioforce AG
  • Strategic Direction
  • Key Facts
  • Company Background
  • Production
  • Competitive Positioning
  • Ivf Hartmann AG
  • Strategic Direction
  • Key Facts
  • Company Background
  • Production
  • Competitive Positioning
  • Spirig Pharma AG
  • Strategic Direction
  • Key Facts
  • Company Background
  • Production
  • Competitive Positioning
  • Streuli Pharma AG
  • Strategic Direction
  • Key Facts
  • Company Background
  • Production
  • Competitive Positioning
  • Vifor Fribourg SA
  • Strategic Direction
  • Key Facts
  • Company Background
  • Production
  • Competitive Positioning
  • Trends
  • Sector Data
  • List of Summaries
    • Summary 1 Research Sources
    • Summary 2 Bioforce AG: Key Facts
    • Summary 3 Bioforce AG: Operational Indicators
    • Summary 4 Bioforce AG: Production Statistics 2008
    • Summary 5 Bioforce AG: Competitive Position 2008
    • Summary 6 IVF Hartmann AG: Key Facts
    • Summary 7 IVF Hartmann AG: Operational Indicators
    • Summary 8 IVF Hartmann AG: Competitive Position 2008
    • Summary 9 Spirig Pharma AG: Key Facts
    • Summary 10 Spirig Pharma AG: Operational Indicators
    • Summary 11 Spirig Pharma AG: Production Statistics 2007
    • Summary 12 Spirig Pharma AG: Competitive Position 2008
    • Summary 13 Streuli Pharma AG: Key Facts
    • Summary 14 Streuli Pharma AG: Operational Indicators
    • Summary 15 Streuli Pharma AG: Competitive Position 2008
    • Summary 16 Vifor Pharma: Key Facts
    • Summary 17 Vifor Pharma: Operational Indicators
    • Summary 18 Vifor Pharma: Competitive Position 2008
  • List of Tables
    • Table 1 Consumer Expenditure on Health Goods and Medical Services 2003-2008
    • Table 2 Life Expectancy at Birth 2003-2008
    • Table 3 Sales of OTC Healthcare by Sector: Value 2003-2008
    • Table 4 Sales of OTC Healthcare by Sector: % Value Growth 2003-2008
    • Table 5 OTC Healthcare Company Shares by Value 2004-2008
    • Table 6 OTC Healthcare Brand Shares by Value 2005-2008
    • Table 7 Penetration of Private Label by Sector 2003-2008
    • Table 8 Sales of OTC Healthcare by Distribution Format: % Analysis 2003-2008
    • Table 9 Sales of OTC Healthcare by Sector and Distribution Format: % Analysis 2008
    • Table 10 Forecast Sales of OTC Healthcare by Sector: Value 2008-2013
    • Table 11 Forecast Sales of OTC Healthcare by Sector: % Value Growth 2008-2013
    • Table 12 Sales of Wound Treatments by Subsector: Value 2003-2008
    • Table 13 Sales of Wound Treatments by Subsector: % Value Growth 2003-2008
    • Table 14 Wound Treatments Company Shares by Value 2004-2008
    • Table 15 Wound Treatments Brand Shares by Value 2005-2008
    • Table 16 Forecast Sales of Wound Treatments by Subsector: Value 2008-2013
    • Table 17 Forecast Sales of Wound Treatments by Subsector: % Value Growth 2008-2013